NEW YORK (GenomeWeb) – Thermo Fisher Scientific and Swiss company Biognosys said today that they have signed a comarketing agreement for Thermo Fisher's Orbitrap mass spectrometers and Biognosys' Spectronaut Pulsar software.
The Spectronaut Pulsar software allows researchers to conduct data-independent acquisition (DIA) analyses using data from Orbitrap mass specs. DIA is a method for recording the spectral signatures from all components of a sample, and can be used as a universal method for global expression profiling.
DIA is "an excellent fit for discovery proteomics," Andreas Huhmer, Thermo Fisher's director of proteomics and metabolomics marketing for chromatography and mass spectrometry, said in a statement. It also complements other quantitative techniques such as Tandem Mass Tags and Parallel Reaction Monitoring. "The Spectronaut Pulsar software creates an efficient pipeline for spectral library creation and processing of large DIA datasets," he noted.
Biognosys Chief Technology Officer Lukas Reiter said in a statement that his company developed the software to support its own contract DIA services and for use by research customers. "It has been extensively optimized to take advantage of HRAM data from Orbitrap mass spectrometers as this is the platform we work on ourselves," he said.
As part of the agreement, the two companies will further develop and optimize DIA-related workflows.